{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T19:43:36Z","timestamp":1787341416342,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Special Research Project on Scientific and Technological Innovation Talent, Dingxi Municipal Science and Technology Bureau"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-026-03388-z","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T19:18:14Z","timestamp":1787339894000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of low-dose tirofiban plus dual antiplatelet therapy in acute cerebral infarction beyond the thrombolysis window: a non-randomized trial with preliminary findings"],"prefix":"10.1007","author":[{"given":"Jing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"issue":"10","key":"3388_CR1","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/s1474-4422(24)00369-7","volume":"23","author":"Global","year":"2024","unstructured":"Global (2024) regional, and national burden of stroke and its risk factors, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 23(10):973\u20131003. https:\/\/doi.org\/10.1016\/s1474-4422(24)00369-7","journal-title":"Lancet Neurol"},{"issue":"3","key":"3388_CR2","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","volume":"49","author":"WJ Powers","year":"2018","unstructured":"Powers WJ, Rabinstein AA, Ackerson T et al (2018) 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association. Stroke 49(3):e46\u2013e110. https:\/\/doi.org\/10.1161\/STR.0000000000000158","journal-title":"Stroke"},{"issue":"12","key":"3388_CR3","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T et al (2019) Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association. Stroke 50(12):e344\u2013e418. https:\/\/doi.org\/10.1161\/STR.0000000000000211","journal-title":"Stroke"},{"issue":"3","key":"3388_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","volume":"19","author":"SC Johnston","year":"2018","unstructured":"Johnston SC, Easton JD, Farrant M et al (2018) Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. N Engl J Med 19(3):215\u2013225. https:\/\/doi.org\/10.1056\/NEJMoa1800410","journal-title":"N Engl J Med"},{"issue":"5","key":"3388_CR5","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1161\/STROKEAHA.120.033551","volume":"52","author":"BH Baek","year":"2021","unstructured":"Baek BH, Yoon W, Lee YY, Kim SK, Kim JT, Park MS (2021) Intravenous Tirofiban Infusion After Angioplasty and Stenting in Intracranial Atherosclerotic Stenosis-Related Stroke. Stroke 52(5):1601\u20131608. https:\/\/doi.org\/10.1161\/STROKEAHA.120.033551","journal-title":"Stroke"},{"issue":"2","key":"3388_CR6","doi-asserted-by":"publisher","first-page":"e70070","DOI":"10.1111\/ene.70070","volume":"32","author":"A Arboix","year":"2025","unstructured":"Arboix A, Parra O (2025) Tirofiban Benefits the Outcome of Stroke Patients With Large Artery Atherosclerosis Achieving Full Reperfusion and High NIHSS Scores. Eur J Neurol Feb 32(2):e70070. https:\/\/doi.org\/10.1111\/ene.70070","journal-title":"Eur J Neurol Feb"},{"issue":"18","key":"3388_CR7","doi-asserted-by":"publisher","first-page":"e036318","DOI":"10.1161\/jaha.124.036318","volume":"13","author":"Y Cui","year":"2024","unstructured":"Cui Y, Liu QY, Chen HS (2024) Dual Antiplatelet Therapy and Outcomes in Acute Mild to Moderate Stroke With Versus Without Large-Artery Atherosclerosis Post Hoc Analysis of ATAMIS. J Am Heart Assoc 13(18):e036318. https:\/\/doi.org\/10.1161\/jaha.124.036318","journal-title":"J Am Heart Assoc"},{"issue":"22","key":"3388_CR8","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1056\/NEJMoa2214299","volume":"388","author":"W Zi","year":"2023","unstructured":"Zi W, Song J, Kong W et al (2023) Tirofiban for Stroke without Large or Medium-Sized Vessel Occlusion. N Engl J Med 388(22):2025\u20132036. https:\/\/doi.org\/10.1056\/NEJMoa2214299","journal-title":"N Engl J Med"},{"issue":"2","key":"3388_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/svn-2020-000378","volume":"5","author":"L Liu","year":"2020","unstructured":"Liu L, Chen W, Zhou H et al (2020) Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases. Stroke Vasc Neurol 5(2):159\u2013176. https:\/\/doi.org\/10.1136\/svn-2020-000378","journal-title":"Stroke Vasc Neurol"},{"key":"3388_CR10","doi-asserted-by":"publisher","first-page":"785836","DOI":"10.3389\/fneur.2021.785836","volume":"12","author":"B Han","year":"2021","unstructured":"Han B, Ma T, Liu Z et al (2021) Efficacy and Safety of Tirofiban in Clinical Patients With Acute Ischemic Stroke. Front Neurol 12:785836. https:\/\/doi.org\/10.3389\/fneur.2021.785836","journal-title":"Front Neurol"},{"issue":"8","key":"3388_CR11","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1177\/17474930251326423","volume":"20","author":"Y Qiao","year":"2025","unstructured":"Qiao Y, Zhao M, Wang J et al (2025) Stroke etiology was associated with tirofiban efficacy in acute ischemic stroke without endovascular treatment: A pre-specified subgroup analysis of the TREND trial. Int J Stroke 20(8):977\u2013986. https:\/\/doi.org\/10.1177\/17474930251326423","journal-title":"Int J Stroke"},{"issue":"2","key":"3388_CR12","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.atherosclerosis.2009.07.041","volume":"208","author":"M Blanco","year":"2010","unstructured":"Blanco M, Sobrino T, Montaner J et al (2010) Stroke with polyvascular atherothrombotic disease. Atherosclerosis 208(2):587\u2013592. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.07.041","journal-title":"Atherosclerosis"},{"issue":"6","key":"3388_CR13","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/jamaneurol.2024.0868","volume":"81","author":"W Zhao","year":"2024","unstructured":"Zhao W, Li S, Li C et al (2024) Effects of Tirofiban on Neurological Deterioration in Patients With Acute Ischemic Stroke: A Randomized Clinical Trial. JAMA Neurol 81(6):594\u2013602. https:\/\/doi.org\/10.1001\/jamaneurol.2024.0868","journal-title":"JAMA Neurol"},{"issue":"3","key":"3388_CR14","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/FJC.0000000000001077","volume":"78","author":"H Zhang","year":"2021","unstructured":"Zhang H, Lin F, Zhao Y et al (2021) Assessing the Efficacy and Safety of Tirofiban in Combination With Dual-antiplatelet Therapy in Progressive Ischemic Stroke Patients. J Cardiovasc Pharmacol 78(3):448\u2013452. https:\/\/doi.org\/10.1097\/FJC.0000000000001077","journal-title":"J Cardiovasc Pharmacol"},{"key":"3388_CR15","doi-asserted-by":"publisher","first-page":"987859","DOI":"10.3389\/fneur.2022.987859","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu Y, Xiao Q, Shi Z et al (2022) Safety and efficacy of low-dose and long-course tirofiban in large hemispheric infarction. Front Neurol 13:987859. https:\/\/doi.org\/10.3389\/fneur.2022.987859","journal-title":"Front Neurol"},{"issue":"1","key":"3388_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5853\/jos.2021.02740","volume":"24","author":"M Goyal","year":"2022","unstructured":"Goyal M, McDonough R, Fisher M, Ospel J (2022) The Challenge of Designing Stroke Trials That Change Practice: MCID vs. Sample Size and Pragmatism. J Stroke 24(1):49\u201356. https:\/\/doi.org\/10.5853\/jos.2021.02740","journal-title":"J Stroke"},{"issue":"4","key":"3388_CR17","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1161\/strokeaha.111.674671","volume":"44","author":"JC Stewart","year":"2013","unstructured":"Stewart JC, Cramer SC (2013) Patient-reported measures provide unique insights into motor function after stroke. Stroke 44(4):1111\u20131116. https:\/\/doi.org\/10.1161\/strokeaha.111.674671","journal-title":"Stroke"},{"issue":"5","key":"3388_CR18","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1159\/000528805","volume":"52","author":"M Heinze","year":"2023","unstructured":"Heinze M, Cheng B, Cho TH et al (2023) Predictors of Early Neurological Improvement and Its Relationship to Thrombolysis Treatment and Long-Term Outcome in the WAKE-UP Study. Cerebrovasc Dis 52(5):560\u2013566. https:\/\/doi.org\/10.1159\/000528805","journal-title":"Cerebrovasc Dis"},{"issue":"6","key":"3388_CR19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1136\/neurintsurg-2022-019008","volume":"15","author":"H Kobeissi","year":"2023","unstructured":"Kobeissi H, Ghozy S, Bilgin C, Kadirvel R, Kallmes DF (2023) Early neurological improvement as a predictor of outcomes after endovascular thrombectomy for stroke: a systematic review and meta-analysis. J Neurointerv Surg 15(6):547\u2013551. https:\/\/doi.org\/10.1136\/neurintsurg-2022-019008","journal-title":"J Neurointerv Surg"},{"issue":"1","key":"3388_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000536436","volume":"54","author":"S Torres-Riera","year":"2025","unstructured":"Torres-Riera S, Arboix A, Parra O, Garc\u00eda-Eroles L, S\u00e1nchez-L\u00f3pez MJ (2025) Predictive Clinical Factors of In-Hospital Mortality in Women Aged 85 Years or More with Acute Ischemic Stroke. Cerebrovasc Dis 54(1):11\u201319. https:\/\/doi.org\/10.1159\/000536436","journal-title":"Cerebrovasc Dis"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03388-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-026-03388-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03388-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T19:18:15Z","timestamp":1787339895000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-026-03388-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":20,"alternative-id":["3388"],"URL":"https:\/\/doi.org\/10.1007\/s11239-026-03388-z","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"1 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declared that they have no conflicts of interest regarding this work.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of Dingxi Second People\u2019s Hospital (Approval No. 2025001). Written informed consent was waived by the ethics committee due to the retrospective nature of the study. All methods were carried out in accordance with Declaration of Helsinki.","order":4,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}